A versatile method for conjugating lipid nanoparticles on T cells through combination of click chemistry and metabolic glycoengineering
Authors:
- 4 January 2024
- journal article
- research article
- Published by Wiley in Biotechnology Journal
- Vol. 19 (1) , e2300339
Abstract
Cell‐mediated drug delivery by conjugating nanomedicine to the surface of living cells is a promising strategy for enhancing the efficacy of both drug delivery and cell therapy. It exploits the tissue homing properties of the specific cell types to overcome in vivo barriers and forms a drug depot by directly putting the therapeutic payload in target cells. An important concern of developing this system is the method to conjugate nanoparticles on cells. Herein, we developed a bioorthogonal T cell conjugation strategy using SPAAC click chemistry, which allows controllable and highly efficient conjugation without affecting the viability and functions of the cytotoxic T lymphocytes. Azide groups were incorporated on the surface of T cells through metabolic glycoengineering, followed by reacting with dibenzylcyclooctyne (DBCO) modified lipid nanoparticles (LNPs). LNPs can be conjugated to T cells, allowing for the loading of different drug molecules on the cells. The metabolic engineering and click reaction approach provides a simple and versatile strategy to conjugate NPs to living cells and enable the development of sophisticated therapeutic cell products.Keywords
This publication has 22 references indexed in Scilit:
- Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug deliveryNature Biotechnology, 2018
- Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for ImmunotherapyBioconjugate Chemistry, 2018
- Transition from fractional to classical Stokes–Einstein behaviour in simple fluidsRoyal Society Open Science, 2017
- Exploiting homing abilities of cell carriers: Targeted delivery of nanoparticles for cancer therapyBiochemical Pharmacology, 2017
- Cell-mediated delivery of synthetic nano- and microparticlesJournal of Controlled Release, 2017
- Lipid Nanoparticle Systems for Enabling Gene TherapiesMolecular Therapy, 2017
- Engineered T cells: the promise and challenges of cancer immunotherapyNature Reviews Cancer, 2016
- Hitchhiking nanoparticles: Reversible coupling of lipid-based nanoparticles to cytotoxic T lymphocytesBiomaterials, 2016
- Chemical remodelling of cell surfaces in living animalsNature, 2004
- Peptidotriazoles on Solid Phase: [1,2,3]-Triazoles by Regiospecific Copper(I)-Catalyzed 1,3-Dipolar Cycloadditions of Terminal Alkynes to AzidesThe Journal of Organic Chemistry, 2002